Lv1
58 积分 2022-10-07 加入
Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study
1个月前
已完结
Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia
1个月前
已完结
Liver — guardian, modifier and target of sepsis
3个月前
已完结
Current status and future trends of the global burden of MASLD
5个月前
已完结
GLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes
5个月前
已完结
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
6个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
6个月前
已完结
Cardiovascular–kidney–metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
6个月前
已完结
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management
6个月前
已完结
National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature
6个月前
已完结
皖公网安备34019202002308
